NuPathe Inc news

   Watch this stock
Showing stories 1 - 10 of about 17   

Articles published

PATH 2.74 -0.05 (-1.79%)
price chart
Penny Stock Buzzers: Advanced Cell Technology, Inc. (OTCBB:ACTC), Applied ...
NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders.
Related articles »  
Second IPO in less than a week
With investors largely shying away from the high-risk, high-reward biopharmaceutical sector during the country's recent turbulent economic times, just three drug developers in the Philadelphia region - Adolor Corp., Tengion and NuPathe - have ...
Related articles »  
Calls Trade in PATH
NuPathe, Inc. develops therapeutics for diseases of the central nervous system including neurological and psychiatric disorders.
NuPathe Announces Allowance of Additional U.S. Patent Application for ZECUITY
CONSHOHOCKEN, PA--(Marketwired - May 28, 2013) - NuPathe Inc. ( NASDAQ : PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S.
Related articles »  
First biopharm IPO in three years proposed
Onconova Therapeutics Inc., a Bucks County biopharmaceutical company that is specializing in developing new cancer treatments, has filed plans for an initial public stock offering.
Safeguard Scientifics to Host Investor Day on October 8, 2013
AdvantEdge Healthcare Solutions, Inc. -- Crescendo Bioscience, Inc. -- Good Start Genetics, Inc. -- MediaMath, Inc. -- Medivo, Inc. -- NuPathe Inc. (NASDAQ:PATH) -- Putney, Inc. -- Sotera Wireless, Inc. -- ThingWorx, Inc. Please note that presenting ...
Related articles »  
Skin patch for migraines receives FDA approval
According to NuPathe Inc., the makers and marketers of Zecuity, the patch is effective in treating migraine headache pain as well as migraine-related nausea.
Drug Delivery Partnering Terms and Agreements
Big pharma drug delivery partnering company profiles Abbott Actavis Inc (formerly Watson Pharmaceuticals) Actavis (merged with Watson Pharmaceuticals Oct 2012) Actelion Allergan Amgen Astellas AstraZeneca Baxter International Bayer Biogen Idec ...
Related articles »  
Walnut Creek Energy Finishes Construction on Natural Gas-Fired Power Plant in ...
Quick Links. Home · Industrial News · About Us · Plant Buyer's Guide. � 2013 ALL RIGHTS RESERVED. Industrial Info Resources, Inc. : EEO Policy | Veteran Rights | Privacy Policy | Terms & Conditions | Site Map.